| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Director
2 companies
Steinhart Richard I serves as a Chief Financial Officer at BTAI and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 4 buys and 9 sells. Those positions are worth an estimated $32K at current prices.
Historically, Steinhart Richard I's trades have earned a strong insider score of 87/100 across 7 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +82.7%.
The biggest single holding is BTAI (~$25K) as Chief Financial Officer. The recent filings there lean toward selling, a net 18,883 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2018 | BTAI Bioxcel Therapeutics, Inc. | Chief Financial Officer | Buy | 500 | $5.00 | $2,500.00 | New | |
| Apr 14, 2016 | ATNM Actinium Pharmaceuticals, Inc. | Director | Buy | 2,500 | $2.01 | $5,025.00 | New |